share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Seidman Christine E

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Seidman Christine E

默沙東 | 4:持股變動聲明-董事 Seidman Christine E
美股SEC公告 ·  07/03 01:30

牛牛AI助理已提取核心訊息

Christine E Seidman of Merck & Co., Inc. (MRK) has engaged in a transaction involving the company's common stock on June 28, 2024. The action involved a direct holding of 100 shares of Merck & Co. Following the transaction, Seidman's total direct holdings in the company remain at 100 shares. The nature of the transaction and the price per share were not disclosed in the announcement.
Christine E Seidman of Merck & Co., Inc. (MRK) has engaged in a transaction involving the company's common stock on June 28, 2024. The action involved a direct holding of 100 shares of Merck & Co. Following the transaction, Seidman's total direct holdings in the company remain at 100 shares. The nature of the transaction and the price per share were not disclosed in the announcement.
默沙東公司的克莉絲汀·E·賽德曼(Christine E Seidman)於2024年6月28日參與了一項涉及該公司普通股的交易。該交易涉及持有默沙東公司100股的直接持股。交易後,賽德曼在公司中的總直接持股量仍爲100股。公告中未披露交易性質和每股價格。
默沙東公司的克莉絲汀·E·賽德曼(Christine E Seidman)於2024年6月28日參與了一項涉及該公司普通股的交易。該交易涉及持有默沙東公司100股的直接持股。交易後,賽德曼在公司中的總直接持股量仍爲100股。公告中未披露交易性質和每股價格。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。